Marex Group »

Immunovant shares owned by Marex Group

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Marex Group from 13F filings

Historical chart of Marex Group investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Marex Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Marex Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $397k 16k 24.84

More positions owned by Marex Group

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Broadcom (AVGO)
Lumentum Hldgs Put Option (LITE)
Microsoft Corporation Call Option (MSFT)
Mastercard Incorporated Cl A Put Option (MA)
UnitedHealth (UNH)
Strategy Cl A New (MSTR)
Tesla Motors (TSLA)
Eli Lilly & Co. Put Option (LLY)
Goldman Sachs Put Option (GS)
Booking Holdings (BKNG)
Sandisk Corp (SNDK)
NVIDIA Corporation Call Option (NVDA)
Valkyrie Bitcoin (BRRR)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Marex Group

Top funds holding Immunovant

FMR
Deep Track Capital
Vanguard Group
BlackRock
Armistice Capital
Baker Bros. Advisors
T. Rowe Price Investment Management
TCG Crossover Management
Morgan Stanley
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Two Seas Capital
Jennison Associates
Rtw Investments

View all funds holding Immunovant